On Monday, Black Diamond Therapeutics Inc (BDTX) stock saw a modest uptick, ending the day at $4.35 which represents a slight increase of $0.12 or 2.84% from the prior close of $4.23. The stock opened ...

The Dow Jones closed lower by around 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 23.80% ...

Black Diamond Group Limited rents and sells modular ... including rental of accommodations and surface equipment, and provision of turnkey lodging and travel management logistics services in ...

Clarus Corporation faces challenges but boasts insider buying and a 2.2% yield. See more about the investment potential of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Black Diamond Therapeutics, Inc. (BDTX) announced positive initial Phase 2 results for BDTX-1535 in patients with relapsed or ...

Black Diamond Therapeutics (BDTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on ...

Skiers and snowboarders can take advantage of HUGE savings on new and gently used winter gear with proceeds supporting the ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...